Review: Newer second-line drugs for diabetes are not more cost-effective than sulfonylureas

Natalia Genere, Victor Manuel Montori

Research output: Contribution to journalComment/debate

2 Scopus citations
Original languageEnglish (US)
Pages (from-to)JC8
JournalAnnals of Internal Medicine
Volume168
Issue number2
DOIs
StatePublished - Jan 16 2018

ASJC Scopus subject areas

  • Internal Medicine

Cite this